Why Incannex Healthcare Inc.’s (IXHL) Stock Is Down 5.30%
As of Monday, May 18, Incannex Healthcare Inc.’s IXHL share price has dipped by 5.30%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn’s disease. The company is headquartered in Melbourne, Australia.
Commentary & Analysis
Why Incannex Healthcare Inc.’s (IXHL) Stock Is Down 8.17%
As of Tuesday, May 12, Incannex Healthcare Inc.’s IXHL share price has dipped by 8.17%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Incannex Healthcare Inc.’s (IXHL) Stock Is Down 10.49%
As of Tuesday, May 12, Incannex Healthcare Inc.’s IXHL share price has dipped by 10.49%, which has investors questioning if this is right time to buy.Tudor Pop
Why Incannex Healthcare Inc.’s (IXHL) Stock Is Up 6.15%
As of Friday, May 01, Incannex Healthcare Inc.’s IXHL share price has surged by 6.15%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Incannex Healthcare Inc.’s (IXHL) Stock Is Up 5.10%
As of Thursday, April 30, Incannex Healthcare Inc.’s IXHL share price has surged by 5.10%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | IXHL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $34.6 | $491.4 | 14% |
|
| Shares Out (Mil) | 12.3 | 42.7 | 24% |
|
| Institutional Ownership | 31.4% | 81.3% | 13% |
|
| Float (Mil) | 10.2 | 45.6 | 19% |
|
| Beta | 2.82 | 0.73 | 97% |
|
| Avg Daily Volume (000s) | 65 | 327 | 32% |
|
| Price Change (52-week) |
(75.8%) | 56.8% | 10% |
|
| Growth | IXHL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.1% | na |
|
| Net Income (5yr) | (17.8%) | (2.4%) | 22% |
|
| EPS (5yr) | (9.6%) | 14.9% | 22 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 46.1% | (15.1%) | 92% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.364) | ($1.566) | ($1.718) | |
| Month Ago EPS | ($0.358) | ($1.692) | ($1.841) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.358) | ($1.692) | ($1.841) | |
| Year/Year Chg | 79.3% | (5.4%) | 22.0% | |
| Financials | IXHL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $416 | na |
|
| Net Income (TTM) (Mil) | ($19) | ($11) | 24% |
|
| EPS (TTM) | ($1.656) | ($0.700) | 17% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | ($7) | 18% |
|
| Net Cash Flow (TTM) (Mil) | $53 | $6 | 70% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($28) | $493 | 1% |
|
| Valuation | IXHL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.51 | 2.15 | 10% |
|
| P/E | na | 17.3 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | IXHL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.4% | na |
|
| Net Margin | na | 3.2% | na |
|
| ROA | (41.3%) | (22.2%) | 13% |
|
| ROE | (47.8%) | (21.0%) | 16% |
|
| Liabilities to Assets | 7.7% | 32.3% | 4% |
|
| F-Score | 4 | 3 | 34% |
|
Incannex Healthcare Inc. did not pass any screens on 10/21/2026.
